tiprankstipranks
Levi & Korsinsky LLP Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline
Class Action

Levi & Korsinsky LLP Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline

THE LAWSUIT: A class action securities lawsuit was filed against Verve Therapeutics, Inc. (VERV) that seeks to recover losses of Verve Therapeutics shareholders who were adversely affected by alleged securities fraud between August 9, 2022 and April 1, 2024

Pick the best stocks and maximize your portfolio:

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants did not fully disclose the circumstances under which the Heart-1 Phase 1b clinical trial of VERVE-101, its investigational gene editing medicine, would be halted; (2) defendants overstated the potential benefits of its proprietary lipid nanoparticle delivery system; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT’S NEXT? If you suffered a loss in Verve Therapeutics stock during the relevant time frame – even if you still hold your shares – go to https://zlk.com/pslra-1/verve-therapeutics-inc-lawsuit-submission-form?wire=18 to learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

Related Articles
TheFlyVerve Therapeutics has positive read from NewAmsterdam data, says Stifel
TheFlyVerve Therapeutics price target lowered to $17 from $20 at RBC Capital
TheFlyVerve Therapeutics price target raised to $32 from $29 at Canaccord
Go Ad-Free with Our App